New Age Alpha Advisors LLC Invests $447,000 in Envista Holdings Co. (NYSE:NVST)

New Age Alpha Advisors LLC purchased a new position in shares of Envista Holdings Co. (NYSE:NVST) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 23,187 shares of the company’s stock, valued at approximately $447,000.

Other large investors also recently bought and sold shares of the company. Cerity Partners LLC increased its stake in shares of Envista by 40.1% in the 3rd quarter. Cerity Partners LLC now owns 37,995 shares of the company’s stock worth $751,000 after acquiring an additional 10,883 shares during the last quarter. Glenmede Trust Co. NA acquired a new stake in Envista during the third quarter worth about $217,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Envista by 0.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 425,502 shares of the company’s stock valued at $8,408,000 after buying an additional 3,199 shares during the period. PEAK6 Investments LLC acquired a new position in Envista in the third quarter valued at approximately $1,144,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in Envista in the third quarter worth approximately $521,000.

Wall Street Analyst Weigh In

NVST has been the subject of a number of research analyst reports. Piper Sandler increased their price target on Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Monday, February 3rd. Jefferies Financial Group boosted their price target on shares of Envista from $20.00 to $22.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. UBS Group lowered their price objective on shares of Envista from $23.00 to $21.00 and set a “neutral” rating for the company in a research report on Monday, March 10th. Needham & Company LLC reissued a “hold” rating on shares of Envista in a research report on Thursday, March 6th. Finally, New Street Research set a $19.00 price target on Envista in a research note on Thursday, March 6th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $20.18.

Envista Stock Performance

Shares of NVST opened at $17.13 on Wednesday. The stock has a 50-day simple moving average of $19.47 and a 200-day simple moving average of $19.59. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. Envista Holdings Co. has a 1 year low of $15.15 and a 1 year high of $23.00. The stock has a market capitalization of $2.95 billion, a PE ratio of -2.64, a PEG ratio of 1.27 and a beta of 1.33.

Envista (NYSE:NVST) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, analysts predict that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.